PHASTAR becomes a CDISC Gold Member
PHASTAR donates SAS programs to FDA/PhUSE Open Source Repository
PHASTAR has today released two SAS useful macros to be available free of charge in the newly launched open source FDA/PhUSE repository. Both macros can create a large number of tables within a clinical trial report. One creates tables of summary statistics for continuous and/or categorical data (for example, tables of demographics). The other creates tables of event counts, such as adverse events, or the number of patients taking specific medications, in a clinical trial.
We believe that pharmaceutical companies should focus their efforts in developing innovative new medicines, and that software development should be either done collaboratively, or left to software development experts. We hope that our donation - one of the first in the FDA/PhUSE repository - will encourage others to donate useful SAS, R, STATA, S+ or other scripts and tools to the statistical and programming community, and we wish the FDA/PhUSE team success in their new venture.
PHASTAR attended Olympic Networking Events.
PHASTAR recently attended two events organised by the UK government to foster the development of business relationships.
The British Business Embassy Life Sciences day was held at Lancaster House in London, and was attended by leading business people in life sciences, as well as the Duke of Kent, and the serving UK health minister, Andrew Lansley.
We also attended the British Business Club, which was held at the newly opened Cutty Sark in Greenwich.
PHASTAR @ PhUSE 2012, Budapest
PHASTAR once again attended the annual 2012 European PhUSE conference. The conference was hosted at the Marriot Hotel in Budapest on the edge of the Danube River.
PhUSE is an organisation that has been running for 10 years, providing a global platform to support partnerships, and to encourage discussion of topics encompassing the work of Data Managers, Biostatisticians, Statistical Programmers and eClinical IT professionals linked to the pharmaceutical industry.